Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Cross-reactivity between Candida albicans and Oral Squamous Cell Carcinoma Revealed by Monoclonal Antibody C7

MARÍA J. RODRÍGUEZ, JOSÉ SCHNEIDER, MARÍA D. MORAGUES, RAFAEL MARTÍNEZ-CONDE, JOSÉ PONTÓN and JOSÉ M. AGUIRRE
Anticancer Research September 2007, 27 (5B) 3639-3643;
MARÍA J. RODRÍGUEZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOSÉ SCHNEIDER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARÍA D. MORAGUES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAFAEL MARTÍNEZ-CONDE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOSÉ PONTÓN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOSÉ M. AGUIRRE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: josemanuel.aguirre@ehu.es
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 5B 3639-3643
PubMed 
17972529

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received April 17, 2007
  • Revision received June 5, 2007
  • Accepted June 8, 2007
  • Published online September 1, 2007.

Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. MARÍA J. RODRÍGUEZ1,
  2. JOSÉ SCHNEIDER2,
  3. MARÍA D. MORAGUES3,
  4. RAFAEL MARTÍNEZ-CONDE1,
  5. JOSÉ PONTÓN4 and
  6. JOSÉ M. AGUIRRE1
  1. 1Departamento de Estomatología, Microbiología y Parasitología, Facultad de Medicina y Odontología, Universidad del País Vasco/EHU, Leioa
  2. 2Departamento de Ciencias de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Fundación Tejerina, Madrid, Spain
  3. 3Departamento de Enfermería, Microbiología y Parasitología, Facultad de Medicina y Odontología, Universidad del País Vasco/EHU, Leioa
  4. 4Departamento de Inmunología, Microbiología y Parasitología, Facultad de Medicina y Odontología, Universidad del País Vasco/EHU, Leioa
  1. Correspondence to: José M. Aguirre, Departamento de Estomatología, Facultad de Medicina y Odontología, Universidad del País Vasco, Apartado 699, 48080 Bilbao, Vizcaya, Spain. Tel: +3494 601 2924, Fax: +3494 464 9266, e-mail: josemanuel.aguirre{at}ehu.es

Cited By...

  • 8 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 27 (5B)
Anticancer Research
Vol. 27, Issue 5B
September-October 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cross-reactivity between Candida albicans and Oral Squamous Cell Carcinoma Revealed by Monoclonal Antibody C7
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
12 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Cross-reactivity between Candida albicans and Oral Squamous Cell Carcinoma Revealed by Monoclonal Antibody C7
MARÍA J. RODRÍGUEZ, JOSÉ SCHNEIDER, MARÍA D. MORAGUES, RAFAEL MARTÍNEZ-CONDE, JOSÉ PONTÓN, JOSÉ M. AGUIRRE
Anticancer Research Sep 2007, 27 (5B) 3639-3643;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Cross-reactivity between Candida albicans and Oral Squamous Cell Carcinoma Revealed by Monoclonal Antibody C7
MARÍA J. RODRÍGUEZ, JOSÉ SCHNEIDER, MARÍA D. MORAGUES, RAFAEL MARTÍNEZ-CONDE, JOSÉ PONTÓN, JOSÉ M. AGUIRRE
Anticancer Research Sep 2007, 27 (5B) 3639-3643;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Characterization of a Monoclonal Antibody Directed against Salmonella enterica Serovar Typhimurium and Serovar [4,5,12:i:-]
  • Google Scholar

More in this TOC Section

  • Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients
  • Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study
  • Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire